Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)

MLA

Ying-Hui Jin, et al. “Treatment and Surveillance for Non-Muscle-Invasive Bladder Cancer: A Clinical Practice Guideline (2021 Edition).” Military Medical Research, vol. 9, no. 1, Aug. 2022, pp. 1–21. EBSCOhost, https://doi.org/10.1186/s40779-022-00406-y.

APA

Ying-Hui Jin, Xian-Tao Zeng, Tong-Zu Liu, Zhi-Ming Bai, Zhong-Ling Dou, De-Gang Ding, Zhi-Lu Fan, Ping Han, Yi-Ran Huang, Xing Huang, Ming Li, Xiao-Dong Li, Yi-Ning Li, Xu-Hui Li, Chao-Zhao Liang, Jiu-Min Liu, Hong-Shun Ma, Juan Qi, Jia-Qi Shi, … the Chinese Urological Doctor Association. (2022). Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Military Medical Research, 9(1), 1–21. https://doi.org/10.1186/s40779-022-00406-y

Chicago

Ying-Hui Jin, Xian-Tao Zeng, Tong-Zu Liu, Zhi-Ming Bai, Zhong-Ling Dou, De-Gang Ding, Zhi-Lu Fan, et al. 2022. “Treatment and Surveillance for Non-Muscle-Invasive Bladder Cancer: A Clinical Practice Guideline (2021 Edition).” Military Medical Research 9 (1): 1–21. doi:10.1186/s40779-022-00406-y.